Which statement about the DuoDote kit is true?

Which statement about the DuoDote kit is true?

• A. It is designed to treat exposure to nerve agents
• B. It treats blister agents
• C. It treats choking agents
• D. It treats all chemical agents

Answer: (A)

The statement is true because the DuoDote kit is specifically designed to treat exposure to nerve agents. It contains antidotes—atropine and pralidoxime (2-PAM)—that counteract the effects of organophosphate nerve agents. Atropine blocks the muscarinic effects of acetylcholine excess (like drooling, sweating, bronchorrhea, bronchospasm, and slowed heart rate), while pralidoxime reactivates acetylcholinesterase, helping to reverse both muscarinic and nicotinic symptoms if given before the enzyme–nerve agent complex ages. Blister agents (vesicants) and choking agents require different management, such as decontamination and supportive care, and there isn’t a single antidote that covers all chemical hazards. So the kit’s purpose is specifically tied to nerve-agent exposure, not to every chemical threat.

The statement is true because the DuoDote kit is specifically designed to treat exposure to nerve agents. It contains antidotes—atropine and pralidoxime (2-PAM)—that counteract the effects of organophosphate nerve agents. Atropine blocks the muscarinic effects of acetylcholine excess (like drooling, sweating, bronchorrhea, bronchospasm, and slowed heart rate), while pralidoxime reactivates acetylcholinesterase, helping to reverse both muscarinic and nicotinic symptoms if given before the enzyme–nerve agent complex ages.

Blister agents (vesicants) and choking agents require different management, such as decontamination and supportive care, and there isn’t a single antidote that covers all chemical hazards. So the kit’s purpose is specifically tied to nerve-agent exposure, not to every chemical threat.